Bridgepoint acquired MyDentist from its long-term owners (likely Palamon Capital Partners and The Carlyle Group). Bridgepoint aims to accelerate the group's pivot from low-margin NHS contracts toward high-growth private treatments (implants, aesthetics, clear aligners). Leveraging its prior success with Oasis Dental Care, Bridgepoint plans to implement a rigorous operational efficiency program, utilizing digitalization and AI to optimize chair utilization and patient triage. Furthermore, MyDentist will serve as a consolidation platform, aggressively acquiring smaller independent practices to realize economies of scale in a fragmented market.

MYDENTIST, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN discount to the 12.8x average currently observed in the Healthcare & Pharma sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.